Pronounced between‐subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers-Reference-Cited by-同舟云学术

Pronounced between‐subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers

Published:2016-06-03 Issue:3 Volume:82 Page:706-716
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Jacobs Bart A. W.¹²,Deenen Maarten J.¹,Pluim Dick¹,Hasselt J. G. Coen¹²,Krähenbühl Martin D.¹,Geel Robin M. J. M.¹,Vries Niels²,Rosing Hilde²,Meulendijks Didier¹,Burylo Artur M.¹,Cats Annemieke³,Beijnen Jos H.¹²⁴,Huitema Alwin D. R.¹²,Schellens Jan H. M.¹⁴

Affiliation:

1. Department of Clinical PharmacologyThe Netherlands Cancer Institute Amsterdam The Netherlands

2. Department of Pharmacy & PharmacologyThe Netherlands Cancer Institute Amsterdam The Netherlands

3. Department of Gastroenterology & HepatologyThe Netherlands Cancer Institute Amsterdam The Netherlands

4. Department of Pharmaceutical SciencesUtrecht University Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13007

Reference48 articles.

1. Clinical pharmacokinetics of 5‐fluorouracil and its metabolites in plasma, urine, and bile;Heggie GD;Cancer Res,1987

2. PharmGKB summary

3. 5-Fluorouracil: mechanisms of action and clinical strategies

4. Capecitabine: have we got the dose right?

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Metabolic Enzyme Activity with Endogenous Substances-current Status, Challenges and Limitations;Current Drug Metabolism;2024-08-16

2. Closed-loop automated drug infusion regulator: A clinically translatable, closed-loop drug delivery system for personalized drug dosing;Med;2024-07

3. Circadian rhythms in CYP2A5 expression underlie the time-dependent effect of tegafur on breast cancer;Biochemical and Biophysical Research Communications;2024-05

4. Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy;Clinical Pharmacology & Therapeutics;2024-01-24

5. Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?;British Journal of Clinical Pharmacology;2023-03-30